2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO mRCC Highlights: Does the Updated KEYNOTE-426 Analysis Support Pembrolizumab + Axitinib Superiority Over Sunitinib? Does Tumor Shrinkage Correlate With OS?

0 views
August 6, 2020
Comments 0
Login to view comments. Click here to Login